• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码RNA RHPN1-AS1通过抑制miR-1299促进卵巢癌的生长和侵袭。

lncRNA RHPN1-AS1 Promotes Ovarian Cancer Growth and Invasiveness Through Inhibiting miR-1299.

作者信息

Zhao Lin, Liu Ting, Zhang Xingna, Zuo Donghua, Liu Chunna

机构信息

Department of Gynaecology, Linyi Cancer Hospital, Linyi 276000, People's Republic of China.

出版信息

Onco Targets Ther. 2020 Jun 10;13:5337-5344. doi: 10.2147/OTT.S248050. eCollection 2020.

DOI:10.2147/OTT.S248050
PMID:32606751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7293985/
Abstract

BACKGROUND

Ovarian cancer (OC) is a big threat for public health. However, the molecular mechanism underlying OC development and progression remains unclear. Although the importance of lncRNA in cancer has been proven, how lncRNA is involved in OC is waiting for further investigation.

MATERIALS AND METHODS

qRT-PCR was performed to test expression level. CCK8 and colony formation were conducted to analyze proliferation. Transwell was conducted to measure migration and invasion. Luciferase reporter assay and pulldown assay were utilized to validate RNA interaction.

RESULTS

lncRNA RHPN1-AS1 was highly expressed in OC tissues. RHPN1-AS1 was positively correlated with OC progression and its high expression indicated a low survival rate. Moreover, knockdown of RHPN1-AS1 significantly inhibited the proliferation, migration and invasion of OC cells, and bioinformatics analysis identified that miR-1299 was sponged by RHPN1-AS1 in OC cells. Knockdown of RHPN1-AS1 markedly promoted miR-1299 expression. Of note, inhibition of miR-1299 reversed the roles of RHPN1-AS1 silencing on suppressing proliferation, migration and invasion.

CONCLUSION

Our study demonstrates that RHPN1-AS1 promotes OC progression via sponging miR-1299, suggesting RHPN1-AS1 may be a novel therapeutic target.

摘要

背景

卵巢癌(OC)对公众健康构成重大威胁。然而,OC发生和进展的分子机制仍不清楚。尽管长链非编码RNA(lncRNA)在癌症中的重要性已得到证实,但lncRNA如何参与OC仍有待进一步研究。

材料与方法

采用qRT-PCR检测表达水平。进行CCK8和集落形成实验分析增殖情况。采用Transwell实验检测迁移和侵袭能力。利用荧光素酶报告基因实验和下拉实验验证RNA相互作用。

结果

lncRNA RHPN1-AS1在OC组织中高表达。RHPN1-AS1与OC进展呈正相关,其高表达提示生存率低。此外,敲低RHPN1-AS1显著抑制OC细胞的增殖、迁移和侵袭,生物信息学分析确定在OC细胞中miR-1299被RHPN1-AS1吸附。敲低RHPN1-AS1明显促进miR-1299表达。值得注意的是,抑制miR-1299可逆转RHPN1-AS1沉默对增殖、迁移和侵袭的抑制作用。

结论

我们的研究表明,RHPN1-AS1通过吸附miR-1299促进OC进展,提示RHPN1-AS1可能是一个新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae84/7293985/ff8919caaeb5/OTT-13-5337-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae84/7293985/56a71ddbecae/OTT-13-5337-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae84/7293985/dbac594443e4/OTT-13-5337-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae84/7293985/593d61037572/OTT-13-5337-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae84/7293985/ff8919caaeb5/OTT-13-5337-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae84/7293985/56a71ddbecae/OTT-13-5337-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae84/7293985/dbac594443e4/OTT-13-5337-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae84/7293985/593d61037572/OTT-13-5337-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae84/7293985/ff8919caaeb5/OTT-13-5337-g0004.jpg

相似文献

1
lncRNA RHPN1-AS1 Promotes Ovarian Cancer Growth and Invasiveness Through Inhibiting miR-1299.长链非编码RNA RHPN1-AS1通过抑制miR-1299促进卵巢癌的生长和侵袭。
Onco Targets Ther. 2020 Jun 10;13:5337-5344. doi: 10.2147/OTT.S248050. eCollection 2020.
2
Rhophilin rho GTPase binding protein 1-antisense RNA 1 (RHPN1-AS1) promotes ovarian carcinogenesis by sponging microRNA-485-5p and releasing DNA topoisomerase II alpha ().RHPN1-AS1 通过海绵吸附 microRNA-485-5p 并释放 DNA 拓扑异构酶 IIα()促进卵巢癌发生。
Bioengineered. 2021 Dec;12(2):12003-12022. doi: 10.1080/21655979.2021.2002494.
3
LncRNA RHPN1-AS1 Targeting miR-625/REG3A Promotes Cell Proliferation And Invasion Of Glioma Cells.靶向miR-625/REG3A的长链非编码RNA RHPN1-AS1促进胶质瘤细胞的增殖和侵袭
Onco Targets Ther. 2019 Sep 26;12:7911-7921. doi: 10.2147/OTT.S209563. eCollection 2019.
4
LncRNA RHPN1-AS1 promoted cell proliferation, invasion and migration in cervical cancer via the modulation of miR-299-3p/FGF2 axis.长链非编码 RNA RHPN1-AS1 通过调节 miR-299-3p/FGF2 轴促进宫颈癌中的细胞增殖、侵袭和迁移。
Life Sci. 2019 Dec 15;239:116856. doi: 10.1016/j.lfs.2019.116856. Epub 2019 Sep 13.
5
RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis.RHPN1-AS1 通过调控 miR-596/IGF2BP2 轴促进肝癌进展。
Curr Pharm Des. 2020;25(43):4630-4640. doi: 10.2174/1381612825666191105104549.
6
LncRNA PSMA3-AS1 Promotes Lung Cancer Growth and Invasion via Sponging MiR-4504.长链非编码RNA PSMA3-AS1通过海绵化miR-4504促进肺癌生长和侵袭。
Cancer Manag Res. 2020 Jul 1;12:5277-5283. doi: 10.2147/CMAR.S253575. eCollection 2020.
7
RHPN1-AS1 promotes cell proliferation and migration via miR-665/Akt3 in ovarian cancer.RHPN1-AS1 通过 miR-665/Akt3 促进卵巢癌细胞的增殖和迁移。
Cancer Gene Ther. 2021 Feb;28(1-2):33-41. doi: 10.1038/s41417-020-0180-0. Epub 2020 May 27.
8
LncRNA RHPN1-AS1 promotes the progression of nasopharyngeal carcinoma by targeting CELF2 expression.长链非编码 RNA RHPN1-AS1 通过靶向 CELF2 表达促进鼻咽癌的进展。
Exp Mol Pathol. 2021 Oct;122:104671. doi: 10.1016/j.yexmp.2021.104671. Epub 2021 Aug 4.
9
lncRNA RHPN1-AS1 promotes the progression of endometrial cancer through the activation of ERK/MAPK pathway.长链非编码RNA RHPN1-AS1通过激活ERK/MAPK信号通路促进子宫内膜癌进展。
J Obstet Gynaecol Res. 2021 Feb;47(2):533-543. doi: 10.1111/jog.14548. Epub 2020 Nov 9.
10
Long noncoding RNA RHPN1-AS1 promotes colorectal cancer progression via targeting miR-7-5p/OGT axis.长链非编码RNA RHPN1-AS1通过靶向miR-7-5p/OGT轴促进结直肠癌进展。
Cancer Cell Int. 2020 Feb 18;20:54. doi: 10.1186/s12935-020-1110-9. eCollection 2020.

引用本文的文献

1
Latest Update on lncRNA in Epithelial Ovarian Cancer-A Scoping Review.上皮性卵巢癌中长链非编码RNA的最新进展——一项综述。
Cells. 2025 Apr 7;14(7):555. doi: 10.3390/cells14070555.
2
Hsa_circ_0001925 promotes malignant progression in triple-negative breast cancer via miR-1299/YY1 axis.Hsa_circ_0001925 通过 miR-1299/YY1 轴促进三阴性乳腺癌的恶性进展。
Thorac Cancer. 2023 Mar;14(8):746-757. doi: 10.1111/1759-7714.14803. Epub 2023 Feb 8.
3
Long non-coding MELTF Antisense RNA 1 promotes and prognosis the progression of non-small cell lung cancer by targeting miR-1299.

本文引用的文献

1
Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.长非编码 RNA GAS5 通过 GAS5-E2F4-PARP1-MAPK 轴抑制上皮性卵巢癌的 DDP 耐药和肿瘤进展。
J Exp Clin Cancer Res. 2019 Aug 7;38(1):345. doi: 10.1186/s13046-019-1329-2.
2
Long non-coding RNA MACC1-AS1 promoted pancreatic carcinoma progression through activation of PAX8/NOTCH1 signaling pathway.长链非编码 RNA MACC1-AS1 通过激活 PAX8/NOTCH1 信号通路促进胰腺癌进展。
J Exp Clin Cancer Res. 2019 Aug 7;38(1):344. doi: 10.1186/s13046-019-1332-7.
3
LncRNA LINC00668 promotes the progression of breast cancer by inhibiting apoptosis and accelerating cell cycle.
长链非编码 MELTF 反义 RNA 1 通过靶向 miR-1299 促进和预测非小细胞肺癌的进展。
Bioengineered. 2022 Apr;13(4):10594-10604. doi: 10.1080/21655979.2022.2063563.
4
Construction and Comprehensive Prognostic Analysis of a Novel Immune-Related lncRNA Signature and Immune Landscape in Gastric Cancer.一种新型免疫相关长链非编码RNA特征及胃癌免疫景观的构建与综合预后分析
Int J Genomics. 2022 Jan 17;2022:4105280. doi: 10.1155/2022/4105280. eCollection 2022.
5
Rhophilin rho GTPase binding protein 1-antisense RNA 1 (RHPN1-AS1) promotes ovarian carcinogenesis by sponging microRNA-485-5p and releasing DNA topoisomerase II alpha ().RHPN1-AS1 通过海绵吸附 microRNA-485-5p 并释放 DNA 拓扑异构酶 IIα()促进卵巢癌发生。
Bioengineered. 2021 Dec;12(2):12003-12022. doi: 10.1080/21655979.2021.2002494.
6
Genome-Wide Screening Identifies Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma.全基因组筛选鉴定出肝癌的预后长非编码 RNA。
Biomed Res Int. 2021 May 20;2021:6640652. doi: 10.1155/2021/6640652. eCollection 2021.
7
The role and underlying mechanism of miR-1299 in cancer.miR-1299在癌症中的作用及潜在机制。
Future Sci OA. 2021 Mar 2;7(6):FSO693. doi: 10.2144/fsoa-2021-0014.
8
Non-Coding RNAs as Biomarkers of Tumor Progression and Metastatic Spread in Epithelial Ovarian Cancer.非编码RNA作为上皮性卵巢癌肿瘤进展和转移扩散的生物标志物
Cancers (Basel). 2021 Apr 12;13(8):1839. doi: 10.3390/cancers13081839.
9
LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms.长链非编码 RNA 在卵巢癌进展、转移及主要通路中的作用: ceRNA 和替代机制
Int J Mol Sci. 2020 Nov 23;21(22):8855. doi: 10.3390/ijms21228855.
长链非编码RNA LINC00668通过抑制细胞凋亡和加速细胞周期来促进乳腺癌的进展。
Onco Targets Ther. 2019 Jul 11;12:5615-5625. doi: 10.2147/OTT.S188933. eCollection 2019.
4
Long noncoding RNA WDFY3-AS2 suppresses tumor progression by acting as a competing endogenous RNA of microRNA-18a in ovarian cancer.长链非编码 RNA WDFY3-AS2 通过作为卵巢癌细胞中 microRNA-18a 的竞争性内源性 RNA 来抑制肿瘤进展。
J Cell Physiol. 2020 Feb;235(2):1141-1154. doi: 10.1002/jcp.29028. Epub 2019 Jul 25.
5
Silencing of the long non-coding RNA RHPN1-AS1 suppresses the epithelial-to-mesenchymal transition and inhibits breast cancer progression.长链非编码RNA RHPN1-AS1的沉默抑制上皮-间质转化并抑制乳腺癌进展。
Am J Transl Res. 2019 Jun 15;11(6):3505-3517. eCollection 2019.
6
Long non-coding RNA FLJ33360 participates in ovarian cancer progression by sponging miR-30b-3p.长链非编码RNA FLJ33360通过吸附miR-30b-3p参与卵巢癌进展。
Onco Targets Ther. 2019 Jun 7;12:4469-4480. doi: 10.2147/OTT.S205622. eCollection 2019.
7
LncRNA HAND2-AS1 exerts anti-oncogenic effects on ovarian cancer via restoration of BCL2L11 as a sponge of microRNA-340-5p.长链非编码 RNA HAND2-AS1 通过作为 microRNA-340-5p 的海绵恢复 BCL2L11 发挥抑癌作用对卵巢癌。
J Cell Physiol. 2019 Dec;234(12):23421-23436. doi: 10.1002/jcp.28911. Epub 2019 Jun 21.
8
Upregulation of hsa_circ_0136666 contributes to breast cancer progression by sponging miR-1299 and targeting CDK6.hsa_circ_0136666 的上调通过海绵吸附 miR-1299 和靶向 CDK6 促进乳腺癌进展。
J Cell Biochem. 2019 Aug;120(8):12684-12693. doi: 10.1002/jcb.28536. Epub 2019 Apr 16.
9
Elevation of circular RNA circ_0005230 facilitates cell growth and metastasis via sponging miR-1238 and miR-1299 in cholangiocarcinoma.环状RNA circ_0005230的上调通过在胆管癌中海绵化miR-1238和miR-1299促进细胞生长和转移。
Aging (Albany NY). 2019 Apr 4;11(7):1907-1917. doi: 10.18632/aging.101872.
10
MiR-1299 functions as a tumor suppressor to inhibit the proliferation and metastasis of prostate cancer by targeting NEK2.miR-1299 通过靶向 NEK2 发挥肿瘤抑制因子的作用,抑制前列腺癌的增殖和转移。
Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):530-538. doi: 10.26355/eurrev_201901_16865.